HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications

HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications

Chronic hepatitis B virus (HBV) infection represents a worldwide public health concern with approximately 250 million people chronically infected and at risk of developing liver cirrhosis and hepatocellular carcinoma. Nucleos(t)ide analogues (NUC) are the most widely used therapies for HBV infection...

Full description

Bibliographic Details
Main Authors: Carolina Boni, Valeria Barili, Greta Acerbi, Marzia Rossi, Andrea Vecchi, Diletta Laccabue, Amalia Penna, Gabriele Missale, Carlo Ferrari, Paola Fisicaro
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:International Journal of Molecular Sciences
Subjects:
Chronic HBV infection
T cell exhaustion
immune-therapy
Online Access:https://www.mdpi.com/1422-0067/20/11/2754

Similar Items

Similar Items